Pharma News
Study Finds Parkinson Disease Drug Nearly Matches Wegovy in Weight Loss Effects
![](https://meefro.com/wp-content/uploads/2024/02/Study-Finds-Parkinson-Disease-Drug-Nearly-Matches-Wegovy-in-Weight-780x470.png)
Early-stage trial results indicate that NLRP3 inflammasome inhibitors were able to achieve nearly the same weight loss as Wegovy while also reducing inflammatory biomarkers linked to heart disease.
Source link
#Study #Finds #Parkinson #Disease #Drug #Matches #Wegovy #Weight #Loss #Effects